e-learning
resources
Munich 2014
Sunday, 07.09.2014
Translational studies in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Microparticles as biomarkers of lung injury in human broncho-alveolar lavage fluid
A. Leclercq, A. Simon, F. Zobairi, F. Toti, L. Kessler, R. Kessler (Strasbourg, Illkirch, France)
Source:
International Congress 2014 – Translational studies in COPD
Session:
Translational studies in COPD
Session type:
Thematic Poster Session
Number:
835
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Leclercq, A. Simon, F. Zobairi, F. Toti, L. Kessler, R. Kessler (Strasbourg, Illkirch, France). Microparticles as biomarkers of lung injury in human broncho-alveolar lavage fluid. Eur Respir J 2014; 44: Suppl. 58, 835
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Cytologicalfeaturesof bronchoalveolar lavage in different variants of exogenous allergic alveolitis
Source: International Congress 2014 – ILDs 5
Year: 2014
Characterization of inflammation in bronchoalveolar lavage of lung transplant patients
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Profile of airway mucins in bronchoalveolar lavage fluid of patients with pulmonary alveolar proteinosis
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Bronchoalveolar lavage fluid leukotrienes in the pathomechanism of acute inflammatory events in lung transplant recipients
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Diagnostic value of pneumocystis-PCR in bronchoalveolar lavage in a clinical setting
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015
Can IL-4Ralpha and PAR-2 in bronchoalveolar lavage fluid serve as biomarker of fibroproliferative healing in interstitial lung diseases?
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Investigation of mitochondria homeostasis and mitophagy in bronchoalveolar lavage fluid (BALF) cells in pulmonary fibrosis
Source: International Congress 2015 – IPF pathogenesis
Year: 2015
Differences in the lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) in lung transplanted patients
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016
The level of bronchoalveolar lavage fluid prostaglandine E2; Is it diagnostic of bronchogenic carcinoma?
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013
Utility of bronchoalveolar lavage in vasculitis patients
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014
Effects of infections on lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) after lung transplantation
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016
Detection of exosomal miRNA in pulmonary sarcoidosis
Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine
Year: 2014
The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Importance of early bronchoalveolar lavage in immunocompromised patients
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Serum and bronchoalveolar exosomal miRNAs in pulmonary sarcoidosis
Source: International Congress 2015 – Sarcoidosis: pathogenesis
Year: 2015
The value of bronchoalveolar lavage in the diagnosis and management of small airway disease
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014
Levels of antimicrobial peptide LL-37 in BALF and ELF from patients with pulmonary fibrosis
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful?
Source: Eur Respir J 2011; 38: 761-769
Year: 2011
Cytotoxic phenotype of alveolar lymphocytes (AL) in bronchoalveolar lavage fluid (BALF) from non-small cell lung cancer (NSCLC) patients
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Usefulness of bronchoalveolar lavage in the diagnosis of desquamative interstitial pneumonia
Source: International Congress 2014 – ILDs 2
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept